Rick Pauls | President, CEO & Director |
Scott Kellen | CFO & Company Secretary |
Etzer Darout | Guggenheim Securities |
Alex Nowak | Craig-Hallum Capital |
Thomas Flaten | Lake Street Capital |
Francois Brisebois | Oppenheimer |
Good morning, ladies and gentlemen. And welcome to the DiaMedica Therapeutics Second Quarter 2021 Conference Call. An audio recording of the webcast will be available shortly after the call today on DiaMedica's website at www.diamedica.com in the Investor Relations section.
Before the company proceeds with its remarks, please note that the company will be making forward-looking statements on today's call. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected in these statements.